Skip to main content
O

OnDosis

OnDosis provides a Dosage Manager that integrates a drug/device combination to deliver precise medication dosages tailored to individual patient needs. This system enhances treatment adherence and enables physicians to monitor and adjust dosing effectively, reducing waste and improving health outcomes.

Mölndal, SwedenFounded 2017401K+ followers
Updated 20 months ago

Funding

$175.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

AM
Funding rounds are not available yet.

Founders

Product

Problem

Many patients struggle with medication adherence due to complex dosing schedules and difficulties in managing multiple medications. This can lead to suboptimal treatment outcomes, increased healthcare costs, and medication waste.

Solution

OnDosis provides a drug/device combination product featuring an intuitive Dosage Manager designed to simplify medication delivery and improve patient adherence. The system dispenses precise, individualized doses with a single click, streamlining the medication-taking process. By integrating the drug and device, OnDosis aims to close the loop between patients and physicians, enabling better monitoring and dosage adjustments. This approach optimizes treatment outcomes, reduces medication waste, and connects patients with essential services and data.

Target Audience

The primary target audience includes patients who require precise and consistent medication dosing, physicians seeking to improve patient adherence and treatment outcomes, and pharmaceutical companies looking to simplify therapy for patients.

Features

  • Intuitive Dosage Manager for simplified medication dispensing
  • Pre-filled starter packs available through retail pharmacies
  • Integrated drug/device combination prescribed by physicians
  • Support for adherence monitoring and dosage adjustments
  • Optimized dosing to minimize waste of unused medications
This profile is AI-generated and may contain inaccuracies.